Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Algernon Pharmaceuticals News

    0,099 € +8,20% +0,0075 €
    17:13:33 Uhr Gettex aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A3DAFG
    ISIN: CA01559R4008
    US-Symbol: AGNPF
    Typ: Aktie

    Algernon Pharmaceuticals News

    01.03.23 - Newsfile
    CSE Bulletin: Stock Split - Algernon Pharmaceuticals Inc. (AGN)
    Toronto, Ontario--(Newsfile Corp. - Le 1 mars/March 2023) - Algernon Pharmaceuticals Inc. has announced a four (4) for one (1) stock split of its issued and outstanding common ...
    01.09.22 - ACCESSWIRE
    The Power Play by The Market Herald Releases New Interviews with Algernon, Permex Petroleum, Infinity Stone, Green River Gold, HIRE Technologies, and Aton Resources Discussing Their Latest News
    VANCOUVER, BC / ACCESSWIRE / September 1, 2022 / The Power Play by The Market Herald has announced the release of new interviews with Algernon, Permex Petroleum, ...
    23.02.22 - ACCESSWIRE
    The Power Play by The Market Herald Releases New Interviews With Algernon Pharmaceuticals, Adastra Holdings and C3 Metals
    VANCOUVER, BC / ACCESSWIRE/ February 23, 2022 / The Power Play by The Market Herald has announced the release of new interviews with Algernon Pharmaceuticals, Adastra ...
    24.01.22 - ACCESSWIRE
    The Power Play by The Market Herald Releases Interviews with Algernon Pharmaceuticals, Newrange Gold, and Fokus Mining
    VANCOUVER, BC / ACCESSWIRE / January 24, 2022 / The Power Play by The Market Herald has announced the release of a new interviews with Algernon Pharmaceuticals, ...
    19.11.21 - ACCESSWIRE
    The Power Play by The Market Herald Interviews Christopher Moreau of Algernon Pharmaceuticals Discussing Their Latest News
    VANCOUVER, BC / ACCESSWIRE / November 19, 2021 / The Power Play by The Market Herald has announced the release of new interviews with Algernon Pharmaceuticals ...
    21.10.21 - GlobeNewswire
    Algernon Pharmaceuticals Announces Receipt of CAD$2M Cash Refund from Australian Research Program and Files Application to List its Common Shares on Nasdaq Capital Market
    VANCOUVER, British Columbia, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or ...
    15.10.21 - ACCESSWIRE
    The Power Play by The Market Herald Announces Interviews with Algernon Pharmaceuticals, NextechAR, UCore Rare Metals, Falcon Gold, and Durango Resources on Latest Company News
    VANCOUVER, BC / ACCESSWIRE / October 15, 2021 / The Market Herald, the leading source of authoritative breaking stock market news for self-​directed investors spoke with ...
    15.12.20 - GlobeNewswire
    Algernon Pharmaceuticals Announces Positive Trending Interim Data for its Phase 2b/3 Ifenprodil COVID Study
    VANCOUVER, British Columbia, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “ Company ” or “ ...
    30.11.20 - GlobeNewswire
    Algernon Pharmaceuticals Announces Enrollment of Final Patient in its Multinational Phase 2b/3 Human Study of Ifenprodil for COVID-19
    VANCOUVER, British Columbia, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “ Company ” or “ ...
    09.11.20 - GlobeNewswire
    Algernon Pharmaceuticals Announces Plans to Provide Interim Data from its Ifenprodil Phase 2b/3 COVID-19 Human Study
    VANCOUVER, British Columbia, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “ Company ” or “ ...
    05.08.20 - GlobeNewswire
    Algernon Announces Enrollment of First Patient in 2b/3 Human Study of Ifenprodil for Treatment of COVID-19
    VANCOUVER, British Columbia, Aug. 05, 2020 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “ Company ” or “ ...
    25.05.20 - GlobeNewswire
    Algernon Submits Investigational New Drug (IND) Application with U.S. FDA for Multinational Phase 2b/3 Human Study to Evaluate Ifenprodil for COVID-19
    VANCOUVER, British Columbia, May 25, 2020 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “ Company ” or “ ...
    06.05.20 - IRW-Press
    Algernon erhält die erste Genehmigung der Ethikkommission für seine Phase-II-Humanstudie zu Ifenprodil in der Behandlung der idiopathischen Lungenfibrose und des chronischen Hustens in Australien
    VANCOUVER, British Columbia, 6. Mai 2020 -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (das Unternehmen oder Algernon) - ein auf ...
    05.05.20 - IRW-Press
    Algernon Pharmaceuticals ändert Konditionen der Privatplatzierung von Special-Warrants
    NICHT ZUR VERBREITUNG ÜBER US-​NACHRICHTENDIENSTE UND NICHT ZUR DIREKTEN ODER INDIREKTEN VERÖFFENTLICHUNG, AUSSENDUNG ODER VERBREITUNG ...
    01.05.20 - IRW-Press
    Algernon Pharmaceuticals meldet Privatplatzierung von Special-Warrants von bis zu $5 Millionen
    NICHT ZUR VERBREITUNG ÜBER US-​NACHRICHTENDIENSTE UND NICHT ZUR DIREKTEN ODER INDIREKTEN VERÖFFENTLICHUNG, AUSSENDUNG ODER VERBREITUNG ...
    30.04.20 - IRW-Press
    Algernon erhält Genehmigung für multinationale klinische Phase-IIb/III-Studie zu Ifenprodil in der Behandlung von COVID-19
    VANCOUVER, British Columbia, 29. April 2020 -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (das Unternehmen oder Algernon) - ein auf ...
    29.04.20 - GlobeNewswire
    Algernon Receives Clearance from Health Canada for Ifenprodil COVID-19 Phase 2b/3 Multinational Clinical Trial
    VANCOUVER, British Columbia, April 29, 2020 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “ Company ” or “ ...
    29.04.20 - IRW-Press
    Algernon präsentiert im Rahmen eines von Dr. KSS, MD, PhD gehosteten BioPub-Spezial-Webcasts „The Science of Ifenprodil“
    VANCOUVER, British Columbia, 29. April 2020 -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (das Unternehmen oder Algernon) - ein auf ...
    23.04.20 - IRW-Press
    Algernon erhält Genehmigung der Regulierungsbehörde und Ethikkommission für seine Phase-II-Humanstudie zu Ifenprodil in der Behandlung von COVID-19 in Südkorea
    VANCOUVER, British Columbia, 23. April 2020 - Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (das Unternehmen oder Algernon) - ein auf ...
    23.04.20 - GlobeNewswire
    Algernon Receives Regulatory and Ethics Approval for Phase 2 Ifenprodil COVID-19 Human Study in South Korea
    VANCOUVER, British Columbia, April 23, 2020 (GLOBE NEWSWIRE) --  Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “ Company ” or “ ...

    Newssuche

    Videos

    26.04.24
    Technical Trading: Gold Long freitags
    Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »